| 臺大學術典藏 |
2022-01-11T06:49:33Z |
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
|
HSIEN-YI CHIU; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:29Z |
Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement
|
Ger T.-Y.; Huang Y.-H.; Hui R.C.-Y.; Tsai T.-F.; HSIEN-YI CHIU |
| 臺大學術典藏 |
2022-01-11T06:49:26Z |
Measurement and prediction of the severity of postinflammatory dyspigmentation after resolution of psoriatic plaques in patients treated with biologic therapy
|
HSIEN-YI CHIU; Chang Liao N.-F.; Hui R.C.-Y.; Lin Y.-J.; Tsai Y.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2022-01-11T06:49:25Z |
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
|
Tsai T.-F.; Hsieh T.-Y.; Chi C.-C.; Chou C.-T.; Hsieh L.-F.; Chen H.-H.; Hui R.C.-Y.; Lee C.-H.; Liu C.-H.; Liu H.-C.; Yeo K.-J.; Chen C.-H.; Chen H.-A.; Chen Y.-C.; Chen Y.-J.; HSIEN-YI CHIU; Ho J.-C.; Huang Y.-H.; Lai P.-J.; Lee W.-R.; Liao H.-T.; Lin S.-H.; Tseng J.-C.; Wang T.-S.; Wu N.-L.; Yang D.-H.; Tsai W.-C.; Wei J.C.-C.; Taiwan Rheumatology Association (TRA); the Taiwanese Association for Psoriasis; Skin Immunology (TAPSI) |
| 臺大學術典藏 |
2022-01-11T06:49:24Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
HSIEN-YI CHIU; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; Tsai T.-F.; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-10-28T07:11:18Z |
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
|
TSEN-FANG TSAI; Hsieh T.-Y.; Chi C.-C.; Chou C.-T.; Hsieh L.-F.; Chen H.-H.; Hui R.C.-Y.; Lee C.-H.; Liu C.-H.; Liu H.-C.; Yeo K.-J.; Chen C.-H.; Chen H.-A.; Chen Y.-C.; Chen Y.-J.; Chiu H.-Y.; Ho J.-C.; Huang Y.-H.; Lai P.-J.; Lee W.-R.; Liao H.-T.; Lin S.-H.; Tseng J.-C.; Wang T.-S.; Wu N.-L.; Yang D.-H.; Tsai W.-C.; Wei J.C.-C.; Taiwan Rheumatology Association (TRA); the Taiwanese Association for Psoriasis; Skin Immunology (TAPSI) |
| 臺大學術典藏 |
2021-10-28T07:11:16Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
Chiu H.-Y.; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; TSEN-FANG TSAI; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-09-07T08:28:47Z |
The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLA
|
Chen, C-B; Chen, Y-E; Chu, M-T; Wang, C-W; Hui, R C-Y; Lu, C-W; Hsiao, Y-P; CHIA-YU CHU; Chang, M M; Cheung, C M-T; Cheng, C-Y; Wang, Y-W; Lin, Y-J; Chang, C-J; Hung, S-I; Chung, W-H |
| 國立成功大學 |
2021 |
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians
|
Wang, C.-W.;Tassaneeyakul, W.;Chen, Chen C.-B.;Chen, W.-T.;Teng, Y.-C.;Huang, C.-Y.;Sukasem, C.;Lu, C.-W.;Lee, Y.-S.;Choon, S.-E.;Nakkam, Nakkam N.;Hui, R.C.-Y.;Huang, Y.-H.;Chang, Y.-C.;Lin, Y.Y.-W.;Chang, Chang C.-J.;Chiu, T.-M.;Chantratita, W.;Konyoung, P.;Lee, C.-N.;Klaewsongkram, J.;Rerkpattanapipat, T.;Amornpinyo, W.;Saksit, N.;Rerknimitr, P.;Huang, Y.H.;Lin, S.-H.;Hsu, C.-K.;Chan, Chan C.-C.;Lin, Y.-J.;Hung, S.-I.;Chung, W.-H.;Consortium, Taiwan/Asian Severe Cutaneous Adverse Reaction |
| 國立成功大學 |
2021 |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
Chiu, H.-Y.;Chiu, Y.-M.;Chang, Liao N.-F.;Chi, Chi C.-C.;Tsai, Tsai T.-F.;Hsieh, C.-Y.;Hsieh, T.-Y.;Lai, K.-L.;Chiu, T.-M.;Wu, N.-L.;Hui, R.C.-Y.;Lee, C.-N.;Wang, T.-S.;Chen, P.-H.;Yang, C.-C.;Huang, Y.-H. |
| 臺大學術典藏 |
2020-10-22T07:27:48Z |
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
|
TSEN-FANG TSAI; Wang T.-S.; Lai P.-J.; Tsai Y.-C.; Chen K.-L.; Huang R.-Y.; Huang Y.-H.; Hui R.C.-Y.; Chiu H.-Y.; Chiu H.-Y.;Hui R.C.-Y.;Huang Y.-H.;Huang R.-Y.;Chen K.-L.;Tsai Y.-C.;Lai P.-J.;Wang T.-S.;Tsen-Fang Tsai |
| 臺大學術典藏 |
2019-12-04T08:43:56Z |
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
|
Hung S.-I.;Chung W.-H.;Liu Z.-S.;Chen C.-H.;Hsih M.-S.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-T.; Hung S.-I.; Chung W.-H.; Liu Z.-S.; Chen C.-H.; Hsih M.-S.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-T. |
| 臺大學術典藏 |
2019-12-04T08:43:56Z |
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
|
Hung S.-I.;Chung W.-H.;Liu Z.-S.;Chen C.-H.;Hsih M.-S.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-T.; Hung S.-I.; Chung W.-H.; Liu Z.-S.; Chen C.-H.; Hsih M.-S.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-T. |
| 臺大學術典藏 |
2019-12-04T08:43:33Z |
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
|
Chen C.-B.;Hsiao Y.-H.;Wu T.;Hsih M.-S.;Tassaneeyakul W.;Jorns T.P.;Sukasem C.;Hsu C.-N.;Su S.-C.;Chang W.-C.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Sun P.-L.;Lee H.-E.;Yang C.-Y.;Kao P.-H.;Yang C.-H.;Ho H.-C.;Lin J.-Y.;Chang Y.-C.;Chen M.-J.;Lu C.-W.;Ng C.Y.;Kuo K.-L.;Lin C.-Y.;Yang C.-S.;Chen D.-P.;Chang P.-Y.;Wu T.-L.;Lin Y.-J.;Weng Y.-C.;Kuo T.-T.;Hung S.-I.;Chung W.-H.;For The Taiwan Severe Cutaneous Adverse Reaction Consortium; Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium |
| 臺大學術典藏 |
2019-12-04T08:43:33Z |
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
|
Chen C.-B.;Hsiao Y.-H.;Wu T.;Hsih M.-S.;Tassaneeyakul W.;Jorns T.P.;Sukasem C.;Hsu C.-N.;Su S.-C.;Chang W.-C.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Sun P.-L.;Lee H.-E.;Yang C.-Y.;Kao P.-H.;Yang C.-H.;Ho H.-C.;Lin J.-Y.;Chang Y.-C.;Chen M.-J.;Lu C.-W.;Ng C.Y.;Kuo K.-L.;Lin C.-Y.;Yang C.-S.;Chen D.-P.;Chang P.-Y.;Wu T.-L.;Lin Y.-J.;Weng Y.-C.;Kuo T.-T.;Hung S.-I.;Chung W.-H.;For The Taiwan Severe Cutaneous Adverse Reaction Consortium; Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium |
| 臺大學術典藏 |
2019-12-04T08:43:28Z |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium; Huang Y.-H.; Lu C.-W.; Chiu T.-M.; Hsu C.-K.; Wu C.-Y.; Chen Y.-J.; CHIA-YU CHU; Hui R.C.-Y.; Cheng B.; Ji C.; Huang J.-W.; Cheung C.M.-T.; Wang Y.-H.;Chen C.-B.;Tassaneeyakul W.;Saito Y.;Aihara M.;Choon S.E.;Lee H.Y.;Chang M.M.;Roa F.D.;Wu C.-W.;Zhang J.;Nakkam N.;Konyoung P.;Okamoto-Uchida Y.;Cheung C.M.-T.;Huang J.-W.;Ji C.;Cheng B.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Huang Y.-H.;Lu C.-W.;Yang C.-Y.;Lin Y.-T.;Chi M.-H.;Ho H.-C.;Lin J.-Y.;Yang C.-H.;Chang Y.-C.;Su S.-C.;Wang C.W.;Fan W.-L.;Hung S.-I.;Chung W.-H.;For The Asian Severe Cutaneous Adverse Reaction Consortium; Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y. |
| 臺大學術典藏 |
2019-12-04T08:43:28Z |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium; Huang Y.-H.; Lu C.-W.; Chiu T.-M.; Hsu C.-K.; Wu C.-Y.; Chen Y.-J.; CHIA-YU CHU; Hui R.C.-Y.; Cheng B.; Ji C.; Huang J.-W.; Cheung C.M.-T.; Wang Y.-H.;Chen C.-B.;Tassaneeyakul W.;Saito Y.;Aihara M.;Choon S.E.;Lee H.Y.;Chang M.M.;Roa F.D.;Wu C.-W.;Zhang J.;Nakkam N.;Konyoung P.;Okamoto-Uchida Y.;Cheung C.M.-T.;Huang J.-W.;Ji C.;Cheng B.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Huang Y.-H.;Lu C.-W.;Yang C.-Y.;Lin Y.-T.;Chi M.-H.;Ho H.-C.;Lin J.-Y.;Yang C.-H.;Chang Y.-C.;Su S.-C.;Wang C.W.;Fan W.-L.;Hung S.-I.;Chung W.-H.;For The Asian Severe Cutaneous Adverse Reaction Consortium; Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y. |
| 國立成功大學 |
2019 |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Wang, Y.-H.;Chen, Chen C.-B.;Tassaneeyakul, W.;Saito, Y.;Aihara, M.;Choon, S.E.;Lee, H.Y.;Chang, M.M.;Roa, F.D.;Wu, C.-W.;Zhang, J.;Nakkam, Nakkam N.;Konyoung, P.;Okamoto-Uchida, Y.;Cheung, Cheung C.M.-T.;Huang, J.-W.;Ji, C.;Cheng, B.;Hui, R.C.-Y.;Chu, Chu C.-Y.;Chen, Y.-J.;Wu, C.-Y.;Hsu, C.-K.;Chiu, T.-M.;Huang, Y.-H.;Lu, C.-W.;Yang, C.-Y.;Lin, Y.-T.;Chi, M.-H.;Ho, Ho H.-C.;Lin, J.-Y.;Yang, C.-H.;Chang, Y.-C.;Su, Su S.-C.;Wang, C.W.;Fan, W.-L.;Hung, S.-I.;Chung, W.-H.;Consortium, for the Asian Severe Cutaneous Adverse Reaction |
| 臺大學術典藏 |
2018 |
Health-related quality of life among patients with moderate-to-severe plaque psoriasis in Taiwan
|
Tsen-Fang Tsai;Ho J.-C.;Chen Y.-J.;Hsiao P.-F.;Lee W.-R.;Chi C.-C.;Lan C.-C.;Hui R.C.-Y.;Lin Y.-C.;Yang K.-C.;Wong T.-W.;Sheu H.-M.;Hsu H.-C.;Chu G.-Y.;Huang Y.-H.; TSEN-FANG TSAI; Ho J.-C.; Chen Y.-J.; Hsiao P.-F.; Lee W.-R.; Chi C.-C.; Lan C.-C.; Hui R.C.-Y.; Lin Y.-C.; Yang K.-C.; Wong T.-W.; Sheu H.-M.; Hsu H.-C.; Chu G.-Y.; Huang Y.-H. |
| 國立成功大學 |
2018 |
Health-related quality of life among patients with moderate-to-severe plaque psoriasis in Taiwan
|
Tsai, Tsai T.-F.;Ho, J.-C.;Chen, Y.-J.;Hsiao, P.-F.;Lee, W.-R.;Chi, Chi C.-C.;Lan, C.-C.;Hui, R.C.-Y.;Lin, Y.-C.;Yang, K.-C.;Wong, T.-W.;Sheu, H.-M.;Hsu, Hsu H.-C.;Chu, G.-Y.;Huang, Y.-H. |
